Is embolic protection during renal artery intervention really necessary?

Journal of Cardiovascular Surgery

Volumn 48, Issue 4, 2007, Pages 443-453

  Corriere, M A ^a   Crutchley, T A ^a   Edwards, M S ^a,b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

Atherosclerosis; Balloon embolization; Embolism; Filter; Hypertension, renovascular; Renal artery; Renal artery stenosts; Stent; Transluminal angioplasty

Indexed keywords

BIOFILTER; BRAIN CIRCULATION; CLINICAL TRIAL; CORONARY ARTERY BLOOD FLOW; DIASTOLIC BLOOD PRESSURE; ENDOVASCULAR SURGERY; HUMAN; KIDNEY ARTERY EMBOLISM; KIDNEY DYSFUNCTION; NEPHROSCLEROSIS; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROTECTIVE EQUIPMENT; RESTENOSIS; REVIEW; STENT; SURGICAL TECHNIQUE; SYSTOLIC BLOOD PRESSURE;

ANGIOPLASTY; EMBOLISM; ENDARTERECTOMY; HUMANS; RENAL ARTERY OBSTRUCTION; TREATMENT OUTCOME;

EID: 35848933248     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (84)

1. Edwards MS, Hansen KJ, Craven TE, Chert GS, Bleyer AJ, Burke GL et al. Relationships between renovascular disease, blood pressure, and renal function in the elderly: a population-based study. Am J Kidney Dis 2003;41:990-6.
2. Fried LF, Shlipak MG, Cramp C, Bleyer AJ, Gottdiener JS, Kronmal RA et al. Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol 2003; 41:1364-72.
3. Johansson M, Herlitz H, Jensen G, Rundqvist B, Friberg P. Increased cardiovascular mortality in hypertensive patients with renal artery stenosis. Relation to sympathetic activation, renal function and treatment regimens. J Hypertens 1999;17:1743-50.
4. Shlipak MG, Fried LF, Cramp C, Bleyer AJ, Manolio TA, Tracy RP et al. Cardiovascular disease risk status in elderly persons with renal insufficiency. Kidney Int 2002;62:997-1004.
5. Burkland CE, Goodwin WE, Leadbetter WF. The cure of hypertension by nephrectomy; a ten-year follow-up of a case. Surgery 1950;28:67-70.
6. Smith HW. Unilateral nephrectomy in hypertensive disease. J Urol 1956;76:685-701.
7. Gruntzig A, Kuhlmann U, Vetter W, Lutolf U, Meier B, Siegenthaler W. Treatment of renovascular hypertension with pereutaneous transluminal dilatation of a renal-artery stenosis. Lancet 1978; 1:801-2.
8. Plouin PF, Chatellier G, Darne B, Raynaud A. Blood pressure outcome of angioplasty in atherosderotic renal artery stenosis. A randomized trial. Hypertension 1998;31:823-9.
9. van Jaarsveld BC, Krijnen P, Pieterman H, Derkx FH, Deinum J, Postma CT et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. N Engl J Med 2000;342:1007-14.
10. Webster J, Marshall F, Abdalla M, Dominiczak A, Edwards R, Isles CG et al. Randomised comparison of pereutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. J Hum Hypertens 1998;12:329-35.
11. Baumgartner I, von Aesch K, Do DD, Triller J, Birrer M, Mahler F. Stent placement in ostial and nonostial atherosclerotic renal arterial stenoses: a prospective follow-up study. Radiology 2000;216:498-505.
12. Cherr GS, Hansen KJ, Craven TE, Edwards MS, Ligush J Jr, Levy PJ et al. Surgical management of atherosclerotic renovascular disease. J Vasc Surg 2002;35:236-45.
13. Hansen KJ, Cherr GS, Craven TE, Motew SJ, Travis JA, Wong JM et al. Management of ischemic nephropathy: dialysis-free survival after surgical repair. J Vasc Surg 2000;32:472-81.
14. Henry M, Amor M, Henry I, Ethevenot G, Tzvetanov K, Courvoisier A et al. Stents in the treatment of renal artery stenosis: long-term follow-up. J Endovasc Surg 1999;6:42-51.
15. Lederman RJ, Mendelsohn FO, Santos R, Phillips HR, Stack RS, Crowley JJ. Primary renal artery stenting: characteristics and outcomes after 363 procedures. Am Heart J 2001;142:314-23.
16. Marone LK, Clouse WD, Doter DJ, Brewster DC, Lamuraglia GM, Watkins MT et al. Preservation of renal function with surgical revascularization in patients with atherosclerotic renovascular disease. J Vasc Surg 2004;39:322-9.
17. Tuttle KR, Chouinard RF, Webber JT, Dahlstrom LR, Short RA, Henneberry KJ et al. Treatment of atherosclerotic ostial renal artery stenosis with the intravascular stent. Am J Kidney Dis 1998;32:611-22.
18. Duda SH, Banz K, Brehme U, Erley CM, Albes J, Tepe G et al. Cost-effectiveness analysis of treatment of renal-artery stenoses by medication, angioplasty, stenting and surgery. Minim Invasive Ther Allied Technol 2000;10:55-65.
19. Weibull H, Bergqvist D, Jendteg S, Lindgren B, Persson U, Jonsson K et al. Clinical outcome and health care costs in renal revascularization-percutaneous transluminal renal angioplasty versus reconstructive surgery. Br J Surg 1991;78:620-4.
20. Knipp BS, Dimick JB, Eliason JL, Cowan JA, Henke PK, Proctor MS et al. Diffusion of new technology for the treatment of renovascular hypertension in the United States: surgical revascularization versus catheter-based therapy, 1988-2001. J Vasc Surg 2004; 40:717-23.
21. Murphy TP, Soares G, Kim M. Increase in utilization of percutaneous renal artery interventions by Medicare beneficiaries, 1996-2000. Am J Roentgenol 2004;183:561-8.
22. Edwards MS, Craven TE, Burke GL, Dean RH, Hansen KJ. Renovascular disease and the risk of adverse coronary events in the elderly: a prospective, population-based study. Arch Intern Meal 2005;165:207-13.
23. Fatica RA, Port FK, Young EW. Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States. Am J Kidney Dis 2001;37:1184-90.
24. Edwards MS, Hansen KJ, Craven TE, Dean RH, Hansen KJ. Associations between renovascular disease and prevalent cardiovascular disease in the elderly: a population-based study. Vase Endovascular Surg 2004;38:25-35.
25. Cambria RP, Brewster DC, L'Italien GJ, Gertler JP, Abbott WM, LaMuraglia GM et al. Renal artery reconstruction for the preservation of renal function. J Vasc Surg 1996;24:371-80.
26. Novick AC. Long-term results of surgical revascularization for renal artery disease. Urol Clin North Am 2001;28:827-31, x.
27. Novick AC. Surgical revascularization for renal artery disease: current status. BJU Int 2005;95 Suppl 2:75-7.
28. Leertouwer TC, Gussenhoven EJ, Bosch JL, van Jaarsveld BC, van Dijk LC, Deinum J et al Stent placement for renal arterial stenosis: where do we stand? A recta-analysis. Radiology 2000;216:78-85.
29. Zeller T, Frank U, Muller C, Burgelin K, Sinn L, Bestehorn HP et al. Predictors of improved renal function after percutaneous stent-supported angioplasty of severe atherosclerotic ostial renal artery stenosis. Circulation 2003;108:2244-9.
30. Edwards MS, Craven BL, Stafford J, Craven TE, Sauve KJ, Ayerdi J et al. Distal embolic protection during renal artery angioplasty and stenting. J Vasc Surg 2006;44:128-35.
31. Zeller T, Frank U, Muller C, Burgelin K, Sinn L, Horn B et al. Stent-supported angioplasty of severe atherosclerotic renal artery stenosis preserves renal function and improves blood pressure control: long-term results from a prospective registry of 456 lesions. J Endovasc Ther 2004;11:95-106.
32. White CJ. Catheter-based therapy for atherosclerotic renal artery stenosis. Circulation 2006;113:1464-73.
33. Lefkovits J, Holmes DR, Califf RM, Safian RD, Pieper K, Keeler G et al. Predictors and sequelae of distal embolization during saphenous vein graft intervention from the CAVEAT-II trial. Coronary Angioplasty Versus Excisional Atherectomy Trial. Circulation 1995;92:734-40.
34. Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosderotic vascular disease. Circulation 2000;101:570-80.
35. Hong MK, Mehran R, Dangas G, Mintz GS, Lansky AJ, Pichard AD et al. Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality Circulation 1999;100:2400-5.
36. Angelini A, Rubartelli P, Mistrorigo F, Della Barbera M, Abbadessa F, Vischi M et al. Distal protection with a filter device during coronary stenting in patients with stable and unstable angina. Circulation 2004;110:515-21.
37. Dixon SR, Mann JT, Lauer MA, Casale PN, Dippel EJ, Strumpf RK et al. A randomized, controlled trial of saphenous vein graft intervention with a filter-based distal embolic protection device: TRAP trial. J Interv Cardiol 2005;18:233-41.
38. Rogers C, Huynh R, Seifert PA, Chevalier B, Schofer J, Edelman ER et al. Embolic protection with filtering or occlusion balloons during saphenous vein graft stenting retrieves identical volumes and sizes of particulate debris. Circulation 2004;109:1735-40.
39. Stone GW, Webb J, Cox DA, Brodie BR, Qureshi M, Kalynych A et al. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA 2005;293:1063-72.
40. van Gaal WJ, Choudhury RP, Porto I, Channon K, Banning A, Dzavik V et al. Prediction of distal embolization during percutaneous coronary intervention in saphenous vein grafts. Am J Cardiol 2007;99:603-6.
41. Bairn DS, Wahr D, George B, Leon MB, Greenberg J, Cutlip DE et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 2002;105:1285-90.
42. Gick M, Jander N, Bestehorn HP, Ferenc M, Werner K, Comberg T et al. Randomized evaluation of the effects of filter-based distal protection on myocardial perfusion and infarct size after primary percutaneous catheter intervention in myocardial infarction with and without ST-segment elevation. Circulation 2005;112:1462-9.
43. Stone GW, Rogers C, Hermiller J, Feldman R, Hall P, Haber R et al. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation 2003;108:548-53.
44. Ackerstaff RG, Vos JA. TCD-detected cerebral embolism in carotid endarterectomy versus angioplasty and stenting of the carotid bifurcation. Acta Chir Belg 2004;104:55-9.
45. Orlandi G, Fanucchi S, Fioretti C, Acerbi G, Puglioli M, Padolecchia R et al. Characteristics of cerebral microembolism during carotid stenting and angioplasty alone. Arch Neurol 2001;58:1410-3.
46. Crawley F, Stygall J, Lunn S, Harrison M, Brown MM, Newman S. Comparison of microembolism detected by transcranial Doppler and neuropsychological sequelae of carotid surgery and percutaneous transluminal angioplasty. Stroke 2000;31:1329-34.
47. Jordan WD Jr, Voellinger DC, Doblar DD, Plyushcheva NP, Fisher WS, McDowell HA. Microemboli detected by transcranial Doppler monitoring in patients during carotid angioplasty versus carotid endarterectomy. Cardiovasc Surg 1999;7:33-8.
48. Angelini A, Reimers B, Della Della Barbera M, Sacca S, Pasquetto G, Cernetti C et al. Cerebral protection during carotid artery stenting: collection and histopathologic analysis of embolized debris. Stroke 2002;33:456-61.
49. Ohki T, Veith FJ, Grenell S, Lipsitz EC, Gargiulo N, McKay J el al. Initial experience with cerebral protection devices to prevent embolization during carotid artery stenting. J Vasc Surg 2002;36:1175-85.
50. DeRubertis BG, Chaer RA, Gordon R, Bell H, Hynecek RL, Pieracci FM et al. Determining the quantity and character of carotid artery embolic debris by electron microscopy and energy dispersive spectroscopy. J Vasc Surg 2007;45:716-24.
51. Sprouse LR, Peeters P, Bosiers M. The capture of visible debris by distal cerebral protection filters during carotid artery stenting: Is it predictable? J Vasc Surg 2005;41:950-5.
52. Reimers B, Corvaja N, Moshiri S, Saccà S, Albiero R, Di Mario C et al. Cerebral protection with filter devices during carotid artery stenting. Circulation 2001;104:12-5.
53. Tubler T, Schluter M, Dirsch O, Sievert H, Bösenberg I, Grebe E et al. Balloon-protected carotid artery stenting: relationship of periprocedural neurological complications with the size of particulate debris. Circulation 2001;104:2791-6.
54. Henry M, Polydorou A, Henry I, Polydorou A, Hugel M. Carotid angioplasty under cerebral protection with the PercuSurge GuardWire System. Catheter Cardiovasc Interv 2004;61:293-305.
55. Whitlow PL, Lylyk P, Londero H, Mendiz OA, Mathias K, Jaeger H et al. Carotid artery stenting protected with an emboli containment system. Stroke 2002;33:1308-14.
56. Al-Mubarak N, Roubin GS, Vitek JJ, Iyer SS, New G, Leon MB. Effect of the distal-balloon protection system on microembolization during carotid stenting. Circulation 2001;104:1999-2002.
57. Vos JA, van den Berg JC, Ernst SM, Suttorp MJ, Overtoom TT, Mauser HW et al. Carotid angioplasty and stent placement: comparison of transcranial Doppler US data and clinical outcome with and without filtering cerebral protection devices in 509 patients. Radiology 2005;234:493-9.
58. Hammer FD, Lacroix V, Duprez T, Grandin C, Verhelst R, Peeters A et al. Cerebral microembolization after protected carotid artery stenting in surgical high-risk patients: results of a 2-year prospective study. J Vasc Surg 2005;42:847-53.
59. Pinero P, Gonzalez A, Mayol A, Martinez E, Gonzalez-Marcos JR, Boza F et al. Silent ischemia after neuroprotected percutaneous carotid stenting: a diffusion-weighted MRI study. AJNR Am J Neuroradiol 2006;27:1338-45.
60. Rapp JH, Wakil L, Sawhney R, Pan XM, Yenari MA, Glastonbury C et al. Subclinical embolization after carotid artery stenting: new lesions on diffusion-weighted magnetic resonance imaging occur postprocedure. J Vasc Surg 2007;45:867-72.
61. Schluter M, Tubler T, Steffens JC, Mathey DG, Schofer J. Focal ischemia of the brain after neuroprotected carotid artery stenting. J Am Coil Cardiol 2003;42:1007-13.
62. Cosottini M, Michelassi MC, Puglioli M, Lazzarotti G, Orlandi G, Marconi F et al. Silent cerebral ischemia detected with diffusion-weighted imaging in patients treated with protected and unprotected carotid artery stenting. Stroke 2005;36:2389-93.
63. Kastrup A, Nagele T, Groschel K, Schmidt F, Vogler E, Schulz J, Ememann U et al. Incidence of new brain lesions after carotid stenting with and without cerebral protection. Stroke 2006;37:2312-6.
64. Mas JL, Chatellier G, Beyssen B, Branchereau A, Moulin T, Becquemin JP et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006;355:1660-71.
65. Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004;351:1493-501.
66. Gray WA, Hopkins LN, Yadav S, Davis T, Wholey M, Atkinson R et al. Protected carotid stenting in high-surgical-risk patients: the ARCHeR results. J Vasc Surg 2006;44:258-68.
67. Cremonesi A. The SPIDER Embolic Protection Device performance evaluation in the carotid artery during percutaneous transluminal angioplasty and or stenting. J Invasive Cardiol 2005;17:463-7.
68. Cremonesi A, Manetti R, Liso A, Ricci E, Bianchi P, Castriota F. Endovascular treatment of soft carotid plaques: a single-center carotid stent experience. J Endovasc Ther 2006;13:190-5.
69. Safian RD, Bacharach JM, Ansel GM, Criado FJ. Carotid stenting with a new system for distal embolic protection and stenting in highrisk patients: the carotid revascularization with ev3 arterial technology evolution (CREATE) feasibility trial. Catheter Cardiovasc Interv 2004;63:1-6.
70. Reimers B, Schluter M, Castriota F, Tübler T, Corvaja N, Cernetti C et al. Routine use of cerebral protection during carotid artery stenting: results of a multicenter registry of 753 patients. Am J Med 2004;116:217-22.
71. Kastrup A, Groschel K, Schulz JB, Nagele T, Ernemann U. Clinical predictors of transient ischemic attack, stroke, or death within 30 days of carotid angioplasty and stenting. Stroke 2005;36:787-91.
72. Cremonesi A, Manetti R, Setacci F, Setacci C, Castriota F. Protected carotid stenting: clinical advantages and complications of embolic protection devices in 442 consecutive patients. Stroke 2003;34:1936-41.
73. Edwards MS, Corriere MA, Craven TE, Pan XM, Rapp JM, Pearce JD et al. Atheroembolization during percutaneous renal artery revascularization. J Vasc Surg 2007.
74. Henry M, Klonaris C, Henry I, Tzetanov K, Le Borgne E, Foliguet B et al. Protected renal stenting with the PercuSurge GuardWire device: a pilot study. J Endovasc Ther 2001;8:227-37.
75. Henry M, Henry I, Klonaris C, Polydorou A, Rath P, Lakshmi G et al. Renal angioplasty and stenting under protection: the way for the future? Catheter Cardiovasc Interv 2003;60:299-312.
76. Hiramoto J, Hansen KJ, Pan XM, Edwards MS, Sawhney R, Rapp JH. Atheroemboli during renal artery angioplasty: an ex vivo study. J Vasc Surg 2005;41:1026-30.
77. Holden A, Hill A. Renal angioplasty and stenting with distal protection of the main renal artery in ischemic nephropathy: early experience. J Vasc Surg 2003;38:962-8.
78. Holden A, Hill A, Jaff MR, Pilmore H. Renal artery stent revascularization with embolic protection in patients with ischemic nephropathy. Kidney Int 2006;70:948-55.
79. Coppi G, Moratto R, Silingardi R, Rubino P, Sarropago G, Salemme L et al. PRIAMUS-proximal flow blockage cerebral protection during carotid stenting: results from a multicenter Italian registry. J Cardiovasc Surg (Torino) 2005;46:219-27.
80. Eskandari MK. Cerebral embolic protection. Semin Vasc Surg 2005;18:95-100.
81. Ohki T, Veith FJ. Critical analysis of distal protection devices. Semin Vasc Surg 2003;16:317-25.
82. Eskandari MK, Najjar SF, Matsumura JS, Kibbe MR, Morasch MD. Technical limitations of carotid filter embolic protection devices. Ann Vasc Surg 2007 Mar 15; [Epub ahead of print].
83. Pannu N, Wiebe N, Tonelli M. Prophylaxis strategies for contrast-induced nephropathy. JAMA 2006;295:2765-79.
84. Cooper CJ, Murphy TP, Matsumoto A, Steffes M, Cohen DJ, Jaff M et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am Heart J 2006;152:59-66.